[1] IBANEZ B, JAMES S, AGEWALL S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2018, 39(2): 119-177. DOI: 10.1093/eurheartj/ehx393. [2] 杨海涛.急性心肌梗死12小时后行再灌注治疗仍然获益:一项meta分析[D].乌鲁木齐: 新疆医科大学, 2018: 1-25. [3] DZAVÍK V, BULLER C E, LAMAS G A, et al. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada(TOSCA)-2 trial[J]. Circulation, 2006, 114(23): 2449-2457. DOI: 10.1161/CIRCULATIONAHA.106.669432. [4] GIERLOTKA M, GASIOR M, WILCZEK K, et al. Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms(from a prospective national observational study[PL-ACS] )[J]. Am J Cardiol, 2011, 107(4): 501-508. DOI: 10.1016/j.amjcard.2010.10.008. [5] IOANNIDIS J P A, KATRITSIS D G. Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients[J]. Am Heart J, 2007, 154(6): 1065-1071. DOI: 10.1016/j.ahj.2007.07.049. [6] HOCHMAN J S, LAMAS G A, BULLER C E, et al. Coronary intervention for persistent occlusion after myocardial infarction[J]. N Engl J Med, 2006, 355(23): 2395-2407. DOI: 10.1056/NEJMoa066139. [7] JOBS A, MEHTA S R, MONTALESCOT G, et al. Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials[J]. Lancet, 2017, 390(10096): 737-746. DOI: 10.1016/S0140-6736(17)31490-3. [8] AGGARWAL P, REKWAL L, SINHA S K, et al. Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction[J]. Ann Cardiol Angeiol(Paris), 2021, 70(3): 136-142. DOI: 10.1016/j.ancard.2021.04.004. [9] NIU X W, ZHANG J J, BAI M, et al. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis[J]. BMC Cardiovasc Disord, 2018, 18(1): 3. DOI: 10.1186/s12872-017-0722-z. [10] JOLLY S S, JAMES S, DZˇAVÍK V, et al. Thrombus aspiration in ST-segment-elevation myocardial infarction: an individual patient meta-analysis: thrombectomy trialists collaboration[J]. Circulation, 2017, 135(2): 143-152. DOI: 10.1161/CIRCULATIONAHA.116.025371. [11] LI P, RUAN J W, LIU M, et al. Thrombus aspiration catheter improve the myocardial reperfusion of STEMI patients with high Thrombus load during the emergency PCI operation[J]. J Cardiothorac Surg, 2019, 14(1): 172. DOI: 10.1186/s13019-019-0974-z. [12] KHALFALLAH M, ALLAITHY A, MARIA D A. Impact of the total ischemia time on no-reflow phenomenon in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Anatol J Cardiol, 2022, 26(5): 382-387. DOI: 10.5152/AnatolJCardiol.2021.846. [13] CIOFANI J L, ALLAHWALA U K, SCARSINI R, et al. No-reflow phenomenon in ST-segment elevation myocardial infarction: still the Achilles' heel of the interventionalist[J]. Future Cardiol, 2021, 17(2): 383-397. DOI: 10.2217/fca-2020-0077. [14] PAPAPOSTOLOU S, ANDRIANOPOULOS N, DUFFY S J, et al. Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention(PCI): a multicentre Australian registry[J]. EuroIntervention, 2018, 14(2): 185-193. DOI: 10.4244/EIJ-D-17-00269. [15] TASAR O, KARABAY A K, ODUNCU V, et al. Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Coron Artery Dis, 2019, 30(4): 270-276. DOI: 10.1097/MCA.0000000000000726. [16] RUÍZ-AVALOS J A, BAZÁN-RODRÍGUEZ L, ESPINOZA-ESCOBAR G, et al. Predictors in no-reflow phenomenon in acute myocardial infarction with ST-segment elevation[J]. Arch Cardiol Mex, 2022, 92(4): 461-468. DOI: 10.24875/ACM.21000346. [17] CHALIKIAS G, KIKAS P, THOMAIDIS A, et al. A patient with an extensive coronary artery thrombus[J]. Hellenic J Cardiol, 2018, 59(6): 347-348. DOI: 10.1016/j.hjc.2017.11.002. [18] 朱凤玉,张煜,祝锐锐,等.急性ST段抬高型心肌梗死相关动脉血栓自溶二例诊治分析[J].实用心脑肺血管病杂志, 2017, 25(7): 115-117. DOI: 10.3969/j.issn.1008-5971.2017.07.030. [19] 蔡健玉.梗死相关血管自发性再通的相关因素分析[D].上海: 上海交通大学, 2014: 1-10. [20] DEWOOD M A, SPORES J, NOTSKE R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction[J]. N Engl J Med, 1980, 303(16): 897-902. DOI: 10.1056/NEJM198010163031601. [21] 朱建兵,王瑾,周军,等.ST段抬高心肌梗死患者梗死相关动脉自发再通对短期临床预后的影响[J].中华临床医师杂志(电子版), 2013, 7(22): 10006-10010. DOI: 10.3877/cma.j.issn.1674-0785.2013.22.044. [22] ZHUO M F, ZHANG K L, SHEN X B, et al. Postoperative adverse cardiac events in acute myocardial infarction with high thrombus load and best time for stent implantation[J]. World J Clin Cases, 2022, 10(7): 2106-2114. DOI: 10.12998/wjcc.v10.i7.2106. [23] SILVAIN J, COLLET J P, NAGASWAMI C, et al. Composition of coronary thrombus in acute myocardial infarction[J]. J Am Coll Cardiol, 2011, 57(12): 1359-1367. DOI: 10.1016/j.jacc.2010.09.077. [24] SILVAIN J, COLLET J P, GUEDENEY P, et al. Thrombus composition in sudden cardiac death from acute myocardial infarction[J]. Resuscitation, 2017, 113: 108-114. DOI: 10.1016/j.resuscitation.2017.01.030. [25] 张凌宇.急性心肌梗死不同时间段冠脉血栓成分病理分析的研究[J].现代中西医结合杂志, 2015, 24(19): 2096-2097. DOI: 10.3969/j.issn.1008-8849.2015.19. |